Indicators

Latest News about Psychedelic Assisted Therapies

Recent news which mentions Psychedelic Assisted Therapies

< Previous 1 2 Next >

Ireland's First Psychedelic Conference Explores Substances As Mental Health Treatment

October 25, 2024

Beyond The Brain: Heart Activity May Shape Psychedelic Experiences, Study Finds

October 25, 2024

A Roadmap To Healing: First-Ever Veterans' Guide To Psychedelics Now Available

October 22, 2024

Ukraine's Military Veterans Turn To Ketamine For PTSD Treatment As Advocacy Grows

October 18, 2024

How Psychedelic Experiences Affect Couples: New Study Looks Into It

October 17, 2024

News Hampshire Lawmakers Reject Psychedelics Bill Citing Safety Concerns Though Support Continued Research

October 16, 2024

Awakn Partners With University Of Nottingham For Preclinical Testing Of Psychoactive Therapy

October 15, 2024

Enveric Biosciences Advances Testing Of Its Non-Hallucinogenic Psychedelic

October 15, 2024

Could Psilocybin Be A Game-Changer For Millions Battling Depression? New Study Says Yes

October 07, 2024

Psychedelics 2.0: Companies Explore Safer, More Targeted Therapies

October 04, 2024

Missouri Allocates $5M For Psilocybin Research To Treat Opioid Addiction

October 03, 2024

End Of Life Psychedelic Care Launches Directory Connecting Caregivers And Patients

October 03, 2024

Michigan Bill Could Legalize Psychedelic Mushrooms For PTSD Treatment

September 30, 2024

Eliza Dushku's True Calling: From Hollywood Movies To Healing With Psychedelics

September 30, 2024

Minnesota Moves Forward With Psilocybin Therapy Plan, Eyes Broader Psychedelic Reforms

September 26, 2024

Sam Altman's Psychedelic Breakthrough: How The OpenAI Visionary Plans To Transform Mental Health Care With MDMA

September 25, 2024

European Initiative Pushes For Psychedelic Therapy Reform To Address $669B Mental Health Problem: The Goal Is To Gather 1 Million Signatures

September 19, 2024

Ultra-Low-Dose Ketamine May Offer Relief For Opioid Withdrawal, Study Finds

September 18, 2024

Clearmind Medicine Files International Patent For Ibogaine Combination Therapy

September 17, 2024

MDMA Therapy For PTSD Faces FDA Delay: Are There Other Ways Forward?

September 12, 2024

Biden Administration Finalizes Rule To Expand Mental Health Care Access: How This Could Impact The Psychedelics Industry

September 10, 2024

Incannex Secures $60M Financing To Drive Advances In Psychedelic And Cannabinoid Therapies

September 10, 2024

Psyence Biomed Launches First Trial Site In Australia For Phase IIb Psilocybin Study In Palliative Care

September 09, 2024

How Set And Setting Impact The Effects Of LSD, New Study Sheds Light

September 05, 2024

Athletes Embrace Psychedelic Therapy For Concussion Symptoms, More Than One-Third Say It Helps

September 05, 2024

Psychedelic Therapy Needs To Move Beyond Mystical Experiences, Say Researchers In New Study

September 03, 2024

Single-Dose Psilocybin Therapy Shows Promise For Treating Alcohol Use Disorder, Study Finds

August 30, 2024

FDA Sets September Meeting To Discuss Psychedelic And Other Treatments For PTSD

August 28, 2024

Could Psychedelics End Binge Drinking? A Breakthrough Patent Says Yes

August 23, 2024

Psychedelics Enhance Creativity After Use, But MDMA Disrupts Memory, Study Shows

August 23, 2024

< Previous 1 2 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.